Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Han's Union Biotechnology is a Chinese biotechnology company focused on the large-scale production of recombinant proteins using a proprietary yeast expression system. As a subsidiary of Han's Laser Technology Industry Group, the company has developed a robust platform for manufacturing high-purity recombinant human serum albumin (rHSA), which serves as a safer alternative to plasma-derived products. Their product portfolio extends to recombinant human lactoferrin and lysozyme, targeting applications in therapeutics, medical devices, and cell culture. The company operates a state-of-the-art GMP-compliant facility in Beijing, providing both internal product development and contract manufacturing services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Han's Union Biotechnology.